]>
IRCT20210916052504N1 IRCT 2021-11-20 Iran University of Medical Sciences The efficacy of medical versus surgical abortion for first trimester therapeutic in Iran; A quasi experimental analysis The efficacy of medical versus surgical abortion for first trimester therapeutic in Iran; A quasi experimental analysis 2022-02-20 anticipated 140 Complete https://irct.ir/trial/58768 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. N/A Condition 1: Missed abortion. Condition 2: Complications following (induced) termination of pregnancy. Condition 3: (Induced) termination of pregnancy with other and unspecified complications. Intervention 1: Medical intervention with three doses of misoprostol 400 mg (with trade name Cytotec) sublingual and vaginal 6 hours apart. Intervention 2: Dilation and curettage (D & C), the dilation of the cervix and surgical removal of part of the lining of the uterus and/or contents of the uterus by scraping and scooping along with 200 mg of misoprostol at the time of surgery and 6 hours after that. Yes - There is a plan to make this available What will be shared: This research is part of the dissertation of the PhD course in Health Economics, which is conducted at Iran University of Medical Sciences. Any sharing is done by this university. When: Second six month of 1401, central library of iran university of medical sciences To whom: In order to facilitate decisions at the level of the health system and policy makers, by physicians or patient preferences, as well as the researchers Conditions: In order to facilitate decisions at the level of the health system and policy makers, by physicians or patient preferences Where to obtain: Website or Central Library of Iran University of Medical Sciences How to obtain: Website or Central Library of Iran University of Medical Sciences Comments:
public Saeed Husseini Barghazan
School of Health Management and Information Sciences, No. 6, Rashid Yasemi St. Vali –e Asr Ave, Tehran, IRAN
Tehran Iran (Islamic Republic of) 1996713883 +98 21 8867 1615 Hoseyni.sa@iums.ac.ir Iran University of Medical Sciences scientific Setare Nassiri
Firoozgar Hospital, Behafarin St, Karimkhan St, Valiasr square, Tehran, IRAN
Tehran Iran (Islamic Republic of) 1593747811 002188671615 Saeed.husseini1993@gmail.com Iran University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Iran (Islamic Republic of) Women seeking first trimester therapeutic abortion 18 years 45 years Female Illegal abortions Underlying disease (including neoplasms) O02.1 O04 O04.8 Missed abortion Complications following (induced) termination of pregnancy (Induced) termination of pregnancy with other and unspecified complications Treatment - Drugs Treatment - Surgery Medical intervention with three doses of misoprostol 400 mg (with trade name Cytotec) sublingual and vaginal 6 hours apart Dilation and curettage (D & C), the dilation of the cervix and surgical removal of part of the lining of the uterus and/or contents of the uterus by scraping and scooping along with 200 mg of misoprostol at the time of surgery and 6 hours after that Success rate of abortion treatment in the first trimester of pregnancy termonation. Timepoint: The patient's clinical condition based on the physician's opinion 14 days after receiving the first medication or surgery. Method of measurement: Questionnaire, test, imaging and doctor's opinion. Possible side effects of treatment include severe bleeding, need to repeat the abortion process, infection or damage to the uterus. Timepoint: Clinical status of the patient 14 days after receiving the first treatment intervention. Method of measurement: Questionnaire, test, imaging and doctor's opinion. Iran University of Medical Sciences Approved 2020-04-06 Research Ethics Committees of Iran University of Medical Sciences School of Health Management and Information Sciences, No. 6, Rashid Yasemi St. Vali –e Asr Ave, Tehran, Iran. Tehran Tehran Iran (Islamic Republic of)